Kalvista Pharmaceuticals Inc (KALV) PT Raised to $55 at Roth Capital Feb 17, 2021 04:30PM
KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Feb 16, 2021 04:01PM
KalVista Pharmaceuticals (KALV) Prices 5.375M Share Upsized Common Offering at $36/Sh Feb 11, 2021 05:57AM
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock Feb 10, 2021 09:52PM
Roth Capital Defends Kalvista Pharmaceuticals Inc (KALV), Pullback = Buying Opportunity Sep 6, 2019 09:11AM


May 29, 2019 06:07AM Roth Capital Transfers Coverage on Kalvista Pharmaceuticals Inc (KALV) at Buy
Sep 10, 2018 04:01PM KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
Sep 6, 2018 09:17AM KalVista Pharmaceuticals (KALV) Prices 4M Share Common Offering at $17/Sh
Sep 6, 2018 09:15AM KalVista Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jul 10, 2018 07:18AM Roth Capital Starts Kalvista Pharmaceuticals Inc (KALV) at Buy